<h1>Suven Life Sciences Schedules Board Meeting to Discuss Q1 Un-Audited Financial Results</h1>
Suven Life Sciences Ltd has scheduled a meeting of its Board of Directors to review and approve the un-audited financial results for the quarter ended June 30, 2026. The board meeting is set for Thursday, August 6, 2026, with the agenda including consideration of these results and related operational matters.
The company's management will use the meeting to consider both the standalone and consolidated financial performance for the period. This event focuses on providing stakeholders with an update on the company’s standing as reflected in the un-audited figures.
In relation to the Code of Conduct governing insider trading, Suven Life Sciences reported that the Trading Window was closed beginning July 1, 2026. The Trading Window will remain closed until 48 hours following the declaration of the Un-Audited Financial Results of the Company.
SUVEN Stock Price Movement
Shares of Suven Life Sciences Limited closed today after shedding 4.87% to settle at ₹299.25. The stock traded through an intraday range of ₹311.95 to ₹297.55, with a total volume tallying 446,827 shares in the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.